Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma

Journal of the National Cancer Institute

Volumn 92, Issue 22, 2000, Pages 1805-1811

  Kawakami, Kazuyuki ^a   Brabender, Jan ^a   Lord, Reginald V ^b   Groshen, Susan ^b   Greenwald, Bruce D ^c   Krasna, Mark J ^d   Yin, Jing ^c   Fleisher, A Steven ^c   Abraham, John M ^c   Beer, David G ^e   Sidransky, David ^f   Huss, Harold T ^g   Demeester, Tom R ^b   Eads, Cindy ^b   Laird, Peter W ^b   Ilson, David H ^g   Kelsen, David P ^g   Harpole, David ^h   Moore, Mary Beth ^h   Danenberg, Kathleen D ^a   Danenberg, Peter V ^a   Meltzer, Stephen J ^c,d   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Medicine and Research Services   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR MARKER;

ARTICLE; CANCER SURVIVAL; CHROMOSOME 5Q; COLON POLYPOSIS; ESOPHAGUS CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL ANALYSIS;

EID: 0034669126     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.22.1805     Document Type: Article

References (50)

1. The changing epidemiology of esophageal cancer
2. National Cancer Data Base report on esophageal carcinoma
3. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States)
4. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
5. Tumour marker detection in oesophageal carcinoma
6. Microsatellite alterations in serum DNA of head and neck cancer patients
7. Molecular detection of genetic alterations in the serum of colorectal cancer patients
8. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
9. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers
10. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers
11. Aberrations of tumor-suppressor genes (p53, apc, mcc and Rb) in esophageal squamous-cell carcinoma
12. Barrett's esophagus: Metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma
13. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms
14. Evolution of neoplastic cell lineages in Barrett oesophagus
15. APC gene mutations in the mutation cluster region are rare in esophageal cancers
16. Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas
17. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma
18. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelium
19. The role of DNA methylation in cancer genetics and epigenetics
20. Alterations in DNA methylation: A fundamental aspect of neoplasia
21. Cancer epigenetics comes of age
22. p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas
23. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus
24. Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus
25. Allelotype study of esophageal carcinoma
26. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus
27. Allelotype analysis of oesophageal adenocarcinoma: Loss of heterozygosity occurs at multiple sites
28. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers
29. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability
30. E-Cadherin gene promoter hypermethylation in primary gastric carcinomas
31. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B
32. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands
33. A modified and improved method for bisulphite based cytosine methylation analysis
34. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression
35. Asymptotically efficient rank invariant procedures
36. Maximally selected chi square statistics
37. Maximally selected chi square statistics for small samples
38. CpG island methylator phenotype in colorectal cancer
39. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
40. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia
41. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation
42. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
43. p15 (INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing
44. Detection of aberrant promoter hypermethylation of tumor suppressor genes in plasma DNA from non-small cell lung cancer patients
45. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis
46. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer
47. Loss of heterozygosity at 5q21 in non-small cell lung cancer: A frequent event but without evidence of apc mutation
48. Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis
49. Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors
50. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma